Elango R - Search Results

1

Therapeutic targeting of the TPX2/TTK network in colorectal cancer.

Shaath H, Vishnubalaji R, Elango R, Velayutham D, Jithesh PV, Alajez NM. Shaath H, et al. Among authors: elango r. Cell Commun Signal. 2023 Sep 28;21(1):265. doi: 10.1186/s12964-023-01290-2. Cell Commun Signal. 2023. PMID: 37770979 Free PMC article.

2

Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel.

Elango R, Vishnubalaji R, Shaath H, Alajez NM. Elango R, et al. Mol Ther Methods Clin Dev. 2021 Jan 26;20:601-614. doi: 10.1016/j.omtm.2021.01.013. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2021. PMID: 33665229 Free PMC article.

3

Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.

Elango R, Vishnubalaji R, Manikandan M, Binhamdan SI, Siyal AA, Alshawakir YA, Alfayez M, Aldahmash A, Alajez NM. Elango R, et al. Sci Rep. 2019 Sep 23;9(1):13696. doi: 10.1038/s41598-019-50140-0. Sci Rep. 2019. PMID: 31548560 Free PMC article.

4

Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.

Vishnubalaji R, Shaath H, Elango R, Alajez NM. Vishnubalaji R, et al. Among authors: elango r. Semin Cancer Biol. 2020 Oct;65:65-79. doi: 10.1016/j.semcancer.2019.11.006. Epub 2019 Nov 14. Semin Cancer Biol. 2020. PMID: 31733291 Review.

5

MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.

Elango R, Alsaleh KA, Vishnubalaji R, Manikandan M, Ali AM, Abd El-Aziz N, Altheyab A, Al-Rikabi A, Alfayez M, Aldahmash A, Alajez NM. Elango R, et al. Front Oncol. 2020 May 19;10:756. doi: 10.3389/fonc.2020.00756. eCollection 2020. Front Oncol. 2020. PMID: 32509578 Free PMC article.

6

MicroRNA-3148 acts as molecular switch promoting malignant transformation and adipocytic differentiation of immortalized human bone marrow stromal cells via direct targeting of the SMAD2/TGFβ pathway.

Vishnubalaji R, Elango R, Manikandan M, Siyal AA, Ali D, Al-Rikabi A, Hamam D, Hamam R, Benabdelkamel H, Masood A, Alanazi IO, Alfadda AA, Alfayez M, Aldahmash A, Kassem M, Alajez NM. Vishnubalaji R, et al. Among authors: elango r. Cell Death Discov. 2020 Sep 1;6:79. doi: 10.1038/s41420-020-00312-z. eCollection 2020. Cell Death Discov. 2020. PMID: 32922961 Free PMC article.

7

Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy.

Shaath H, Vishnubalaji R, Elango R, Khattak S, Alajez NM. Shaath H, et al. Among authors: elango r. Cell Death Discov. 2021 Jan 25;7(1):23. doi: 10.1038/s41420-020-00383-y. Cell Death Discov. 2021. PMID: 33495450 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 34465732

9

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition.

Elango R, Vishnubalaji R, Shaath H, Alajez NM. Elango R, et al. Cancer Cell Int. 2021 Sep 26;21(1):515. doi: 10.1186/s12935-021-02213-2. Cancer Cell Int. 2021. PMID: 34565361 Free PMC article.

10

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer.

Shaath H, Elango R, Alajez NM. Shaath H, et al. Among authors: elango r. Cancers (Basel). 2021 Oct 26;13(21):5350. doi: 10.3390/cancers13215350. Cancers (Basel). 2021. PMID: 34771513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page